See inside every stock. Pro
WatchlistPro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.36▲ 0.89%

iShares U.S. Pharmaceuticals (IHE)

Healthcare ETF · iShares (BlackRock) · NYSE ARCA · 59 holdings
$104.78 ▲ +2.00 (1.95%)
At close · USD · Volume 316,294
Returns and riskCostIncomeDividend historyHoldingsX-Ray look-throughQuestions
52-week range
$73.76 – $108.66
Day's range
$103.08 – $105.30
1-year total return
+42.3%

IHE price chart

Daily, split-corrected, distributions markedEnd-of-day prices

IHE fund facts

FundiShares U.S. Pharmaceuticals ETF
TickerIHE · NYSE ARCA
Issuer (by our rules)iShares (BlackRock)
Category (by our rules)Healthcare
Expense ratio0.38%
Holdings59
Net assets (fund, SEC)$1.1B
Yield (last 12 months)1.37%
DistributionsQuarterly
52-week range$73.76 – $108.66
Average volume (3 months)232,928
First price in our data5 May 2006
Issuer and category are assigned by StocksXray rules from the fund name. Expense ratio and net assets come from SEC filings; where a fund does not file them (for example grantor trusts) the field stays empty.

Returns and risk

1 month
+1.8%
3 months
+4.4%
6 months
+21.3%
Year to date
+24.6%
1 year
+42.3%
3 years a year
+23.6%
5 years a year
+12.9%
10 years a year
+9.8%
Volatility (1 year)
18.5%
Largest drop, last year
−9.7%
Largest drop in our data
−38.2%
Total return includes distributions, from end-of-day prices adjusted for splits and distributions, to 22 Oct 2026. Periods of 3 years and longer are annualised and shown only when the fund's history is long enough. Volatility is the standard deviation of daily returns over the last year, annualised. Past performance does not guarantee future results.

Cost: expense ratio

0.38% a year

On $10,000 invested that is about $38 a year in fund costs, taken out of the fund's assets.

Source: the fund's prospectus, as filed with the SEC on 22 Jul 2025 (risk/return summary data). Brokerage commissions and the bid-ask spread are separate costs.

Income: distributions

Paid, last 12 months
1.43 USD
Yield on today's price
1.37%
Frequency
Quarterly
Latest ex-date
15 Sep 2026
Full IHE dividend history →
Cash paid per current share (restated for share splits), before tax, from EODHD.

IHE top holdings

#HoldingWeight
1 JOHNSON & JOHNSON JNJ 22.44%
2 ELI LILLY AND COMPANY LLY 22.25%
3 BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares 6.24%
4 MERCK & CO., INC. MRK 4.55%
5 BRISTOL-MYERS SQUIBB COMPANY BMY 4.37%
6 ROYALTY PHARMA PLC 4.34%
7 VIATRIS INC. VTRS 4.22%
8 PFIZER INC. PFE 3.96%
9 ZOETIS INC. ZTS 3.73%
10 JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY 3.45%
The top 10 make up 79.5% of the fund, out of 59 holdings.
Positions as of 30 Jun 2026, from the fund's Form N-PORT filed with the SEC. Public N-PORT holdings are quarter-end positions published about 60 days later, so they can be months old and the fund may have changed since.

X-Ray look-through

StocksXray scores 66% of IHE by weight (7 stocks in our S&P 500 coverage), so we can look inside the fund with our own numbers. The weighted average X-Ray Score of those stocks is 51 out of 100.

Undervalued 12%Fair 81%Overvalued 7%
Health Care 100%
Weights are the SEC holdings weights dated 30 Jun 2026; scores and fair-value labels are today's. Labels follow our fair-value method ("Undervalued" means fair value is more than 17.5% above the price) and are model estimates, not forecasts or advice. How the X-Ray Score works.

Similar Healthcare ETFs

IXJ iShares Global Healthcare0.40% fee · +20.7% 1y VHT Vanguard Health Care0.09% fee · +25.6% 1y PPH VanEck Pharmaceutical0.36% fee · +29.3% 1y IHF iShares U.S. Healthcare Provid...0.38% fee · +20.6% 1y IYH iShares U.S. Healthcare0.38% fee · +25.6% 1y FHLC Fidelity MSCI Health Care Inde...0.08% fee · +25.8% 1y All healthcare ETFs →
Funds of the same category, nearest in trading size. Similar does not mean equivalent: check holdings and costs.

IHE: frequently asked questions

What is IHE?

IHE is the iShares U.S. Pharmaceuticals ETF, issued by iShares (BlackRock), listed on NYSE ARCA. By our rules it is classed as "Healthcare". Its latest SEC filing lists 59 holdings.

What is the expense ratio of IHE?

IHE charges 0.38% a year, according to its prospectus filed with the SEC on 22 Jul 2025. On $10,000 that is about $38 a year in fund costs.

Does IHE pay dividends?

Yes. IHE paid 1.43 per share over the last 12 months, quarterly, a trailing yield of 1.37% on today's price. The latest ex-dividend date was 15 Sep 2026.

What does IHE hold?

The largest holdings in the latest SEC filing are JOHNSON & JOHNSON (22.4%), ELI LILLY AND COMPANY (22.2%), BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares (6.2%). The top 10 together make up 79.5% of the fund.

How has IHE performed?

Total return including distributions to 22 Oct 2026: 1 year +42.3%, 3 years +23.6% a year, 5 years +12.9% a year. Past performance does not guarantee future results.

How does StocksXray rate the stocks inside IHE?

We score 66% of the fund by weight (7 stocks) with our X-Ray Score: the weighted average is 51 out of 100. These are model estimates, not forecasts or advice.

Where the numbers come from

Prices and distributions end-of-day data from EODHD; returns are our own calculations from it.
Expense ratio and holdings SEC filings (prospectus risk/return data and Form N-PORT).
Category, issuer and leverage assigned by StocksXray rules from the fund name.
X-Ray look-through our scores applied to the SEC holdings.
Read the methodology →

StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.